Spironolactone Tablet
Product Images NDC 63629-1061

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
Chemical structure diagram of spironolactone, showing its molecular framework with distinct rings, methyl groups, and functional groups including a lactone and a sulfonyl moiety.*
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
A line graph showing the probability over time in months of two groups: patients treated with spironolactone and those given a placebo. The y-axis represents probability, and the x-axis spans 0 to 48 months. The graph includes a statistical significance value (Log-rank p: <0.001) comparing the groups' outcomes over time.*
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups analyzing the effectiveness of spironolactone versus placebo. Subgroups include age ranges, sex, race, left ventricular ejection fraction (LVEF) percentages, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The N column indicates sample sizes per subgroup.*
FDA Label Image

Lbl636291061

Lbl636291061
Label for Spironolactone Tablets, USP 25 mg by Bryant Ranch Prepack. The label shows the product name, strength (25 mg), and oral tablet dosage form. It includes the NDC 63629-1061-1, manufacturer and relabeler details, a barcode, and package count of 100 tablets. The label has storage instructions and a statement to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.